Regenicin Inc (RGIN) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Regenicin Inc   (RGIN)


Regenicin Inc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Regenicin Inc's ROI in the second quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Regenicin Inc 's return on investment (ROI) in its second quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2023)
II. Quarter		 (Dec 31 2022)
I. Quarter		 (Sep 30 2022)
IV. Quarter		 (Jun 30 2022)
III. Quarter		 (Mar 31 2022)
II. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -6 -6 -5 -5 -5
Return On Investment (TTM) - - - - -
RGIN's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -1 -1 -1 -1 -1

RGIN Company Profile >> Back to RGIN Roi Comparisons >> See Annual RGIN Return On Investment



Return On Investment RGIN's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Regenicin Inc's II. Quarter Investments $ -6 Millions RGIN's Balance sheet
Regenicin Inc's II. Quarter Income $ 0 Millions Quarterly RGIN's Income Statement
RGIN's Income by Division See RGIN's Income by Division


RGIN Annual Return On Investment (Sep 30 2022)
2022		 (Sep 30 2021)
2021		 (Sep 30 2020)
2020		 (Sep 30 2019)
2019		 (Sep 30 2018)
2018
Total Investments in Millions -5 -5 -4 -4 -3
Y / Y Investment Growth - - - - -
Net Income in Millions -1 -1 -1 -1 1
Y / Y Net Income Growth - - - - 1579.26 %
Annual Return On Investment - - - - -


Annual Roi Comment
In the fiscal year 2022 ROI improved to 1579.26 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RGIN's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RGIN's Competitors
Subscribers only: Roi for Regenicin Inc's Suppliers
Subscribers only: Return On Investment for RGIN's Customers

Other Ratios
RGIN's Roa RGIN's Inventory Turnover Ratio RGIN's Growth Rates RGIN's Dividend Statistics
RGIN's Profitability Ratios RGIN's Asset Turnover Ratio RGIN's Dividend Growth
RGIN's Roe RGIN's Valuation Ratios RGIN's Financial Strength Ratios RGIN's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI
Idexx Laboratories Inc  44.27 %
Fuse Medical Inc   43.08 %
Zymeworks Inc   42.67 %
Medpace Holdings Inc   40.11 %
Vaso Corporation  40.00 %
Arcturus Therapeutics Holdings Inc   38.17 %
Mettler toledo International Inc   35.59 %
Assertio Holdings inc   35.55 %
Harmony Biosciences Holdings inc   34.42 %
Catalyst Pharmaceuticals Inc   33.05 %
Nrc Health  31.34 %
Dynavax Technologies Corporation  29.65 %
Semler Scientific inc   28.96 %
Oncotelic Therapeutics Inc   27.82 %
Point Biopharma Global Inc   26.11 %
Moderna Inc   23.91 %
Vertex Pharmaceuticals Inc  22.30 %
Siga Technologies Inc  20.24 %
Innoviva Inc   20.18 %
Pro dex Inc   19.98 %
Chemed Corporation  19.95 %
Edwards Lifesciences Corporation  19.78 %
Corcept Therapeutics Inc  19.07 %
Dr Reddy s Laboratories Limited  19.07 %
Iradimed Corporation  19.01 %
Waters Corporation  18.98 %
Pfizer Inc  18.88 %
West Pharmaceutical Services Inc   18.49 %
Zynex inc   18.06 %
Zoetis Inc   17.90 %

Date modified: 2026-09-08T15:10:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.